advanced breast cancer

Maintaining bone density could be a key to decreasing the spread of cancer in women with locally advanced breast cancer, according to new research.

Bones are common sites for the spread, or metastasis, of breast cancer. Scientists have found that women treated for stage II/III breast cancer who also received a bone strengthening drug were less likely to have breast tumor cells growing in their bones after three months.

NovoCure announced today that it presented the results from a single-arm pilot trial evaluating the Novo-TTF, a non-invasive portable medical device, combined with neo-adjuvant chemotherapy for the treatment of patients with locally advanced breast cancer.

Body Mass Index, the measure of a person's fat based on their height and weight, may be an effective prognostic tool for specific types of breast cancer.

Women with locally advanced breast cancer and inflammatory breast cancer with high BMIs had worse prognosis than women with the disease whose BMIs were in the healthy range.